Eloxatine

Eloxatine (Oxaliplatin) is a chemotherapy medication used to treat certain types of cancer. This intravenous drug is manufactured by Sanofi Winthrop Industrie and is available in the EU.

Eloxatine is primarily used in the treatment of advanced colorectal cancer. It is often combined with other chemotherapy drugs to enhance effectiveness. The medication works by interfering with the growth of cancer cells, making it a key component in cancer treatment protocols.

Common effects of Eloxatine may include nausea, vomiting, and fatigue. Some patients may experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary in severity and duration depending on the individual.

Eloxatine should be handled with care, as it is a potent chemotherapy agent. It is important to follow the guidance of a healthcare professional when administering this medication. Proper protective measures should be taken to avoid exposure to the drug.

Eloxatine may interact with other medications, including certain antibiotics and anticonvulsants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.